CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy: However, its potential as a therapeutic target requires careful evaluation, as immunoglobulin G4 antibodies against Contactin 1 have been linked to chronic inflammatory demyelinating polyneuropathy [65].